StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN)
Stock analysts at StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a report released on Friday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ LPCN opened at $3.30 on Friday. Lipocine has a twelve month low of $2.91 and a twelve month […]
Stock analysts at StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a report released on Friday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ LPCN opened at $3.30 on Friday. Lipocine has a twelve month low of $2.91 and a twelve month […]
